John C. Jacobs is CEO & President at Harmony Biosciences Holdings, Inc. (HRMY). They have made 9 open-market trades across 1 company since 2021, most recently 2026-03-03.
CIK 0001820836
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRMY | SELL | 2022-08-15 | 2022-08-16 | $51.06 | $4.0M | -4.3% | -9.7% | +17.7% |
| HRMY | SELL | 2022-06-15 | 2022-06-16 | $45.42 | $681K | +16.7% | +21.3% | +4.6% |
| HRMY | SELL | 2022-06-13 | 2022-06-14 | $44.18 | $2.2M | +16.8% | +18.7% | +6.2% |
| HRMY | SELL | 2022-03-16 | 2022-03-18 | $45.32 | $680K | +1.1% | +2.3% | -13.9% |
| HRMY | SELL | 2022-03-14 | 2022-03-16 | $42.37 | $2.1M | +6.7% | +5.5% | -7.0% |
| HRMY | SELL | 2022-01-03 | 2022-01-05 | $45.16 | $2.6M | -13.6% | -6.0% | +23.1% |
| HRMY | SELL | 2021-12-27 | 2021-12-29 | $45.03 | $59K | -13.6% | -21.5% | +16.0% |
| HRMY | SELL | 2021-12-13 | 2021-12-15 | $38.21 | $1.9M | +7.1% | -8.6% | +9.2% |
| HRMY | SELL | 2021-09-13 | 2021-09-14 | $35.93 | $898K | +5.5% | +7.7% | +7.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.